In fact, the sensitivities associated with detection of CEA for the diagnosis of CRC are only 4, 25, 44, and 65% in Tumor, Node, Metastasis (TNM) stage I, II, III and IV, respectively [14, 15]. The gene discussed is CEACAM5; the disease is colorectal carcinoma.